Daiwa Securities Group
RDY icon

Daiwa Securities Group’s Dr. Reddy's Laboratories RDY Stock Holding History

Daiwa Securities Group’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-16,500
Closed -$142K – 916
2014
Q2 		$142K Buy
16,500
+6,000
+57% +$50.5K ﹤0.01% 749
2014
Q1 		$92K Hold
10,500
– – ﹤0.01% 779
2013
Q4 		$86K Sell
10,500
-1,500
-13% -$11.9K ﹤0.01% 778
2013
Q3 		$91K Buy
12,000
+1,000
+9% +$7.27K ﹤0.01% 781
2013
Q2 		$83K Buy
+11,000
New +$80.3K ﹤0.01% 792

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Daiwa Securities Group's RDY Position: Q3 2014 in Review

Daiwa Securities Group sold out of Dr. Reddy's Laboratories (RDY) in Q3 2014, closing a stake of 16,500 shares — an estimated $142K sold.

Daiwa Securities Group first reported a position in RDY in Q2 2013 and held it in 5 quarters. The position peaked at $142K in Q2 2014. 159 funds tracked by Wall St. Rank hold RDY as of Q3 2014.

  • Daiwa Securities Group reported no remaining Dr. Reddy's Laboratories position as of Q3 2014 after selling out during the quarter.
  • Daiwa Securities Group sold 16,500 Dr. Reddy's Laboratories shares in Q3 2014, an estimated $142K.
  • Daiwa Securities Group first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 5 quarters.
  • Daiwa Securities Group's Dr. Reddy's Laboratories position peaked at $142K in Q2 2014.
  • 159 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2014.

Based on Daiwa Securities Group's 13F filing for Q3 2014, filed 12 Nov 2014.